AIV
51
3
L
51
2
BF.B
46
2
SRE
44
7
FLR
58
2
NEE
54
-11
WHR
57
-5
NOV
40
-2
SHW
58
2
WDC
61
-4
LLY
68
4
EQT
54
4
NTAP
46
3
SPG
41
3
AON
62
2
STZ
47
2
PHM
46
3
IP
64
2
NEM
50
2
FOX
60
-2
AIV
51
3
L
51
2
BF.B
46
2
SRE
44
7
FLR
58
2
NEE
54
-11
WHR
57
-5
NOV
40
-2
SHW
58
2
WDC
61
-4
LLY
68
4
EQT
54
4
NTAP
46
3
SPG
41
3
AON
62
2
STZ
47
2
PHM
46
3
IP
64
2
NEM
50
2
FOX
60
-2
Financhill
Back

Huhtamäki Oyj 10K Form

Sell
31

HOYFF
Huhtamäki Oyj

Last Price:
$35.40
Seasonality Move:
-4.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HOYFF News And Ratings

See the #1 stock for the next 7 days that we like better than HOYFF

HOYFF Financial Statistics

Sales & Book Value

Annual Sales: $4.5B
Cash Flow: $-24.1M
Price / Cash Flow: 25.37
Annual Sales: $20.86
Price / Book: 1.7

Profitability

EPS (TTM): 2.51290
Net Income (TTM): $262.9M
Gross Margin: $846M
Return on Equity: 12%
Return on Assets: 5.06%

Huhtamäki Oyj Earnings Forecast

Key Huhtamäki Oyj Financial Ratios

  • The Gross Profit Margin over the past 23 years for HOYFF is 18.94%.
  • The Selling, General & Administrative Expenses for HOYFF have been equal to 9.74% of Gross Profit Margin.
  • The Research & Development expenses have been 0.84% of Revenue.
  • The Interest Expense is 35.61% of Operating Income.
  • The Net Earning history of HOYFF is 5.43% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 12 years.

Huhtamäki Oyj Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Containers & Packaging
Sector: Materials
Current Symbol: HOYFF
Website: huhtamaki.com

Debt

Debt-to-Equity Ratio: 0.77
Current Ratio: 1.59
Quick Ratio: 0.95

Price-to-Earnings

Trailing P/E Ratio: 15.36
Forward P/E Ratio: 0

HOYFF Technical Analysis vs Fundamental Analysis

Sell
31
Huhtamäki Oyj (HOYFF) is a Sell

Is Huhtamäki Oyj a Buy or a Sell?

  • Huhtamäki Oyj stock is rated a Sell
    The current Huhtamäki Oyj [HOYFF] share price is $35.40. The Score for HOYFF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.